Loading...
Loading...
Abivax S.A.
Abivax S.A.. Spoken Alpha tracks AAVXF's earnings calls, guidance changes, and executive accountability over time.
Spoken Alpha tracks AAVXF's historical accountability: how often management beat consensus, how the stock reacted, and how guidance evolved across the cycle. The figures below are illustrative placeholder data generated for layout — they will be replaced with real deviation metrics, True Consensus values, and EODHD price reactions as those data layers land.
Misses consensus 10/10 quarters
SampleRepeated misses without a guidance reset suggest management is structurally optimistic relative to operating reality. Track whether next-quarter guidance is being benchmarked off the prior miss or the prior plan.
Missed in 4 of the last 4 quarters
SampleRecent misses matter more than long-window beat rate — the trailing 12 months drives the analyst model and the next-print bar.
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for AAVXF.
curl https://api.spokenalpha.com/v1/companies/AAVXF| Quarter | Actual EPS | Consensus | Surprise | 1D | 5D |
|---|---|---|---|---|---|
| Q1 FY2026 | $1.99 | $2.05 | -2.7% | -2.3% | -3.5% |
| Q4 FY2026 | $1.69 | $1.99 | -15.0% | +5.1% | +5.9% |
| Q3 FY2026 | $1.98 | $2.15 | -8.0% | +0.9% | +2.5% |
| Q2 FY2026 | $2.02 | $2.25 | -10.1% | -3.5% | -1.9% |
| Q1 FY2025 | $1.98 | $2.04 | -2.9% | -0.6% | +0.3% |
| Q4 FY2025 | $2.15 | $2.18 | -1.3% | -4.0% | -6.8% |
| Q3 FY2025 | $2.04 | $2.35 | -13.4% | +6.1% | +8.5% |
| Q2 FY2025 | $2.19 | $2.27 | -3.7% | +2.6% | +4.6% |
| Q1 FY2024 | $2.33 | $2.35 | -1.0% | -2.4% | -2.8% |
| Q4 FY2024 | $2.16 | $2.34 | -7.8% | -3.8% | -6.0% |